05.03.2012 18:50 Uhr, Quelle: Wallstreet online
ThromboGenics Opens New U.S. Headquarters
LEUVEN, Belgium, March 5, 2012 /PRNewswire/ U.S. Organization Continues to Build Ahead of Ocriplasmin´s Planned Launch ThromboGenics NV , a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces the …
Weiterlesen bei Wallstreet online
JustMac.info